Endovascular intervention devices for femoral-popliteal arterial disease have evolved in the last decade to more effectively treat patients with symptoms of claudication, improve tissue healing, and prevent amputation in patients with critical limb ischemia. Drug-eluting stents and drug-coated balloon therapies have demonstrated significant improvements in short- and mid-term patency and decreases in future target vessel interventions over uncoated balloon angioplasty. Adjunctive lesion preparation options including atherectomy devices are available to treat more complex and calcified lesions, but comparative data are still required.
Keywords: Drug-coated balloon; Drug-eluting stent; Femoral-popliteal artery; Percutaneous transluminal angioplasty; Peripheral artery disease; Superficial femoral artery.
Copyright © 2019 Elsevier Inc. All rights reserved.